nodes	percent_of_prediction	percent_of_DWPC	metapath
Naftifine—Tamoxifen—pancreatic cancer	0.542	1	CrCtD
Naftifine—SIGMAR1—Tamoxifen—pancreatic cancer	0.129	1	CbGbCtD
Naftifine—Bedaquiline—Tamoxifen—pancreatic cancer	0.0877	0.291	CrCrCtD
Naftifine—Toremifene—Tamoxifen—pancreatic cancer	0.053	0.176	CrCrCtD
Naftifine—Cyclobenzaprine—Tamoxifen—pancreatic cancer	0.0331	0.11	CrCrCtD
Naftifine—Phenoxybenzamine—Tamoxifen—pancreatic cancer	0.0289	0.0962	CrCrCtD
Naftifine—Clofedanol—Tamoxifen—pancreatic cancer	0.0209	0.0695	CrCrCtD
Naftifine—Orphenadrine—Tamoxifen—pancreatic cancer	0.0202	0.0673	CrCrCtD
Naftifine—Benzphetamine—Tamoxifen—pancreatic cancer	0.0202	0.0673	CrCrCtD
Naftifine—Benzyl Benzoate—Tamoxifen—pancreatic cancer	0.0187	0.0623	CrCrCtD
Naftifine—Diphenhydramine—Tamoxifen—pancreatic cancer	0.018	0.0598	CrCrCtD
Naftifine—Scab—Fluorouracil—pancreatic cancer	0.00154	0.0558	CcSEcCtD
Naftifine—Redness—Tamoxifen—pancreatic cancer	0.00108	0.0389	CcSEcCtD
Naftifine—Blister—Tamoxifen—pancreatic cancer	0.00101	0.0364	CcSEcCtD
Naftifine—Blister—Erlotinib—pancreatic cancer	0.000998	0.036	CcSEcCtD
Naftifine—Blister—Sunitinib—pancreatic cancer	0.000864	0.0312	CcSEcCtD
Naftifine—Inflammation—Tamoxifen—pancreatic cancer	0.00075	0.0271	CcSEcCtD
Naftifine—Inflammation—Erlotinib—pancreatic cancer	0.000742	0.0268	CcSEcCtD
Naftifine—Blister—Fluorouracil—pancreatic cancer	0.000682	0.0246	CcSEcCtD
Naftifine—Stinging—Fluorouracil—pancreatic cancer	0.000606	0.0219	CcSEcCtD
Naftifine—Swelling—Tamoxifen—pancreatic cancer	0.000598	0.0216	CcSEcCtD
Naftifine—Dermatitis bullous—Tamoxifen—pancreatic cancer	0.000552	0.0199	CcSEcCtD
Naftifine—Dermatitis bullous—Erlotinib—pancreatic cancer	0.000546	0.0197	CcSEcCtD
Naftifine—Redness—Docetaxel—pancreatic cancer	0.000525	0.019	CcSEcCtD
Naftifine—Burning sensation—Docetaxel—pancreatic cancer	0.00051	0.0184	CcSEcCtD
Naftifine—Inflammation—Fluorouracil—pancreatic cancer	0.000506	0.0183	CcSEcCtD
Naftifine—Dermatitis bullous—Sunitinib—pancreatic cancer	0.000473	0.0171	CcSEcCtD
Naftifine—Swelling—Fluorouracil—pancreatic cancer	0.000404	0.0146	CcSEcCtD
Naftifine—Dermatitis bullous—Gemcitabine—pancreatic cancer	0.00038	0.0137	CcSEcCtD
Naftifine—Dermatitis bullous—Fluorouracil—pancreatic cancer	0.000373	0.0135	CcSEcCtD
Naftifine—Inflammation—Docetaxel—pancreatic cancer	0.000366	0.0132	CcSEcCtD
Naftifine—Redness—Epirubicin—pancreatic cancer	0.000354	0.0128	CcSEcCtD
Naftifine—Burning sensation—Epirubicin—pancreatic cancer	0.000344	0.0124	CcSEcCtD
Naftifine—Blister—Epirubicin—pancreatic cancer	0.000332	0.012	CcSEcCtD
Naftifine—Redness—Doxorubicin—pancreatic cancer	0.000328	0.0118	CcSEcCtD
Naftifine—Burning sensation—Doxorubicin—pancreatic cancer	0.000319	0.0115	CcSEcCtD
Naftifine—Erythema—Tamoxifen—pancreatic cancer	0.000318	0.0115	CcSEcCtD
Naftifine—Erythema—Erlotinib—pancreatic cancer	0.000314	0.0114	CcSEcCtD
Naftifine—Blister—Doxorubicin—pancreatic cancer	0.000307	0.0111	CcSEcCtD
Naftifine—Stinging—Epirubicin—pancreatic cancer	0.000295	0.0107	CcSEcCtD
Naftifine—Swelling—Docetaxel—pancreatic cancer	0.000292	0.0105	CcSEcCtD
Naftifine—Leukopenia—Tamoxifen—pancreatic cancer	0.000285	0.0103	CcSEcCtD
Naftifine—Stinging—Doxorubicin—pancreatic cancer	0.000273	0.00986	CcSEcCtD
Naftifine—Erythema—Sunitinib—pancreatic cancer	0.000272	0.00983	CcSEcCtD
Naftifine—Dermatitis bullous—Docetaxel—pancreatic cancer	0.000269	0.00972	CcSEcCtD
Naftifine—Agranulocytosis—Gemcitabine—pancreatic cancer	0.000261	0.00942	CcSEcCtD
Naftifine—Agranulocytosis—Fluorouracil—pancreatic cancer	0.000256	0.00926	CcSEcCtD
Naftifine—Inflammation—Epirubicin—pancreatic cancer	0.000247	0.0089	CcSEcCtD
Naftifine—Leukopenia—Sunitinib—pancreatic cancer	0.000244	0.0088	CcSEcCtD
Naftifine—Inflammation—Doxorubicin—pancreatic cancer	0.000228	0.00824	CcSEcCtD
Naftifine—Pain—Tamoxifen—pancreatic cancer	0.000222	0.00801	CcSEcCtD
Naftifine—Pain—Erlotinib—pancreatic cancer	0.000219	0.00792	CcSEcCtD
Naftifine—Erythema—Gemcitabine—pancreatic cancer	0.000218	0.00788	CcSEcCtD
Naftifine—SQLE—islet of Langerhans—pancreatic cancer	0.000215	0.332	CbGeAlD
Naftifine—Erythema—Fluorouracil—pancreatic cancer	0.000215	0.00775	CcSEcCtD
Naftifine—Leukopenia—Irinotecan—pancreatic cancer	0.000201	0.00725	CcSEcCtD
Naftifine—Leukopenia—Gemcitabine—pancreatic cancer	0.000196	0.00706	CcSEcCtD
Naftifine—Leukopenia—Fluorouracil—pancreatic cancer	0.000192	0.00694	CcSEcCtD
Naftifine—Pain—Sunitinib—pancreatic cancer	0.00019	0.00686	CcSEcCtD
Naftifine—Agranulocytosis—Docetaxel—pancreatic cancer	0.000185	0.00668	CcSEcCtD
Naftifine—Pruritus—Tamoxifen—pancreatic cancer	0.000184	0.00662	CcSEcCtD
Naftifine—Dermatitis bullous—Epirubicin—pancreatic cancer	0.000182	0.00656	CcSEcCtD
Naftifine—Pruritus—Erlotinib—pancreatic cancer	0.000182	0.00655	CcSEcCtD
Naftifine—Dizziness—Tamoxifen—pancreatic cancer	0.000172	0.00619	CcSEcCtD
Naftifine—Dizziness—Erlotinib—pancreatic cancer	0.00017	0.00613	CcSEcCtD
Naftifine—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.000168	0.00607	CcSEcCtD
Naftifine—Rash—Tamoxifen—pancreatic cancer	0.000164	0.0059	CcSEcCtD
Naftifine—Dermatitis—Tamoxifen—pancreatic cancer	0.000163	0.0059	CcSEcCtD
Naftifine—Headache—Tamoxifen—pancreatic cancer	0.000163	0.00587	CcSEcCtD
Naftifine—Rash—Erlotinib—pancreatic cancer	0.000162	0.00584	CcSEcCtD
Naftifine—Dermatitis—Erlotinib—pancreatic cancer	0.000162	0.00584	CcSEcCtD
Naftifine—Headache—Erlotinib—pancreatic cancer	0.000161	0.0058	CcSEcCtD
Naftifine—Pruritus—Sunitinib—pancreatic cancer	0.000157	0.00567	CcSEcCtD
Naftifine—Pain—Irinotecan—pancreatic cancer	0.000157	0.00565	CcSEcCtD
Naftifine—Erythema—Docetaxel—pancreatic cancer	0.000155	0.0056	CcSEcCtD
Naftifine—Pain—Gemcitabine—pancreatic cancer	0.000152	0.0055	CcSEcCtD
Naftifine—SQLE—pancreas—pancreatic cancer	0.000151	0.233	CbGeAlD
Naftifine—Pain—Fluorouracil—pancreatic cancer	0.00015	0.00541	CcSEcCtD
Naftifine—Dizziness—Sunitinib—pancreatic cancer	0.000147	0.0053	CcSEcCtD
Naftifine—Rash—Sunitinib—pancreatic cancer	0.00014	0.00506	CcSEcCtD
Naftifine—Dermatitis—Sunitinib—pancreatic cancer	0.00014	0.00505	CcSEcCtD
Naftifine—Headache—Sunitinib—pancreatic cancer	0.000139	0.00502	CcSEcCtD
Naftifine—Leukopenia—Docetaxel—pancreatic cancer	0.000139	0.00501	CcSEcCtD
Naftifine—SQLE—digestive system—pancreatic cancer	0.000129	0.199	CbGeAlD
Naftifine—Pruritus—Gemcitabine—pancreatic cancer	0.000126	0.00455	CcSEcCtD
Naftifine—Agranulocytosis—Epirubicin—pancreatic cancer	0.000125	0.00451	CcSEcCtD
Naftifine—Pruritus—Fluorouracil—pancreatic cancer	0.000124	0.00448	CcSEcCtD
Naftifine—Dizziness—Irinotecan—pancreatic cancer	0.000121	0.00437	CcSEcCtD
Naftifine—Dizziness—Fluorouracil—pancreatic cancer	0.000116	0.00418	CcSEcCtD
Naftifine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000116	0.00417	CcSEcCtD
Naftifine—Rash—Irinotecan—pancreatic cancer	0.000115	0.00417	CcSEcCtD
Naftifine—Dermatitis—Irinotecan—pancreatic cancer	0.000115	0.00416	CcSEcCtD
Naftifine—Headache—Irinotecan—pancreatic cancer	0.000115	0.00414	CcSEcCtD
Naftifine—Rash—Gemcitabine—pancreatic cancer	0.000112	0.00406	CcSEcCtD
Naftifine—Dermatitis—Gemcitabine—pancreatic cancer	0.000112	0.00405	CcSEcCtD
Naftifine—Headache—Gemcitabine—pancreatic cancer	0.000112	0.00403	CcSEcCtD
Naftifine—Rash—Fluorouracil—pancreatic cancer	0.000111	0.00399	CcSEcCtD
Naftifine—Dermatitis—Fluorouracil—pancreatic cancer	0.00011	0.00399	CcSEcCtD
Naftifine—Headache—Fluorouracil—pancreatic cancer	0.00011	0.00396	CcSEcCtD
Naftifine—Pain—Docetaxel—pancreatic cancer	0.000108	0.00391	CcSEcCtD
Naftifine—Erythema—Epirubicin—pancreatic cancer	0.000105	0.00377	CcSEcCtD
Naftifine—Erythema—Doxorubicin—pancreatic cancer	9.67e-05	0.00349	CcSEcCtD
Naftifine—Leukopenia—Epirubicin—pancreatic cancer	9.36e-05	0.00338	CcSEcCtD
Naftifine—SIGMAR1—islet of Langerhans—pancreatic cancer	9.01e-05	0.139	CbGeAlD
Naftifine—Pruritus—Docetaxel—pancreatic cancer	8.95e-05	0.00323	CcSEcCtD
Naftifine—Leukopenia—Doxorubicin—pancreatic cancer	8.66e-05	0.00313	CcSEcCtD
Naftifine—Dizziness—Docetaxel—pancreatic cancer	8.37e-05	0.00302	CcSEcCtD
Naftifine—Rash—Docetaxel—pancreatic cancer	7.98e-05	0.00288	CcSEcCtD
Naftifine—Dermatitis—Docetaxel—pancreatic cancer	7.97e-05	0.00288	CcSEcCtD
Naftifine—Headache—Docetaxel—pancreatic cancer	7.93e-05	0.00286	CcSEcCtD
Naftifine—Pain—Epirubicin—pancreatic cancer	7.3e-05	0.00263	CcSEcCtD
Naftifine—Pain—Doxorubicin—pancreatic cancer	6.75e-05	0.00244	CcSEcCtD
Naftifine—SIGMAR1—pancreas—pancreatic cancer	6.33e-05	0.0976	CbGeAlD
Naftifine—Pruritus—Epirubicin—pancreatic cancer	6.04e-05	0.00218	CcSEcCtD
Naftifine—Dizziness—Epirubicin—pancreatic cancer	5.64e-05	0.00204	CcSEcCtD
Naftifine—Pruritus—Doxorubicin—pancreatic cancer	5.59e-05	0.00202	CcSEcCtD
Naftifine—Rash—Epirubicin—pancreatic cancer	5.38e-05	0.00194	CcSEcCtD
Naftifine—Dermatitis—Epirubicin—pancreatic cancer	5.38e-05	0.00194	CcSEcCtD
Naftifine—Headache—Epirubicin—pancreatic cancer	5.35e-05	0.00193	CcSEcCtD
Naftifine—Dizziness—Doxorubicin—pancreatic cancer	5.22e-05	0.00188	CcSEcCtD
Naftifine—Rash—Doxorubicin—pancreatic cancer	4.98e-05	0.0018	CcSEcCtD
Naftifine—Dermatitis—Doxorubicin—pancreatic cancer	4.97e-05	0.0018	CcSEcCtD
Naftifine—Headache—Doxorubicin—pancreatic cancer	4.95e-05	0.00179	CcSEcCtD
